NCT04570748

Brief Summary

Total hip arthroplasty is a successful surgical procedure performed as a last-line treatment in primary and secondary coxarthrosis. Recently, the direct anterior approach (DAA) has gained popularity by maintaining abduction force and reducing dislocation rates. Soft tissue stability in the anterior is increased by adding capsule repair with the preservation of the posterior structures in the DAA. The degradation of the biological structure of the capsule due to degenerative changes in the end stage coxarthrosis questions the effectiveness of the capsule repair. therefore, the effect of capsule repair on stability is still controversial.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
160

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2020

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 23, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 30, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

November 30, 2020

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2022

Completed
Last Updated

September 30, 2020

Status Verified

September 1, 2020

Enrollment Period

8 months

First QC Date

July 23, 2020

Last Update Submit

September 25, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pelvis magnetic resonance ımages(MRI) evaluation of patients who underwent direct anterior total hip arthroplasty

    The new capsule mass will be evaluated by an independent radiologist. adiologist will evaluate the volume of the new capsule structure in cubic millimeter

    one year

Study Arms (2)

Group A

EXPERIMENTAL

Direct anterior hip arthroplasty with capsule repair.

Procedure: Capsule repair

Group B

ACTIVE COMPARATOR

Surgery that the surgeon will not perform capsule repair after performing an initial capsulectomy during total hip arthroplasty

Procedure: capsulectomy

Interventions

Direct anterior hip arthroplasty with or without capsule repair

Group A
capsulectomyPROCEDURE

capsulectomy without repair

Group B

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elective unilateral or bilateral primary total hip arthroplasty
  • Direct anterior surgical approach
  • years of age or older
  • Avascular necrosis of the hip

You may not qualify if:

  • Rheumatoid arthritis of the hip
  • Revision hip arthroplasty
  • Younger than 18 years of age
  • Crowe type 3 and 4 coxarthrosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Osteoarthritis, Hip

Interventions

Wound Healing

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

RegenerationBiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Recident of orthopaedic surgery

Study Record Dates

First Submitted

July 23, 2020

First Posted

September 30, 2020

Study Start

November 30, 2020

Primary Completion

July 30, 2021

Study Completion

July 30, 2022

Last Updated

September 30, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share